REAVA KHRISTENKO: Open Payments
NPI 1093229379 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,265 in 88 payments from 14 companies in 2025. Trend: 2023 $3,085 · 2024 $3,584 · 2025 $2,265
Food & beverage: $2,265
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $483 |
| Organon LLC | 14 | $430 |
| GENZYME CORPORATION | 4 | $286 |
| Janssen Biotech, Inc. | 9 | $233 |
| Incyte Corporation | 6 | $202 |
| UCB, Inc. | 7 | $180 |
| Lilly USA, LLC | 8 | $148 |
| Galderma Laboratories, L.P. | 6 | $122 |
| Amgen Inc. | 3 | $89 |
| LNHC, Inc | 1 | $24 |
Products named: RINVOQ, DUPIXENT, TREMFYA, OPZELURA, VTAMA, Bimzelx, SKYRIZI, TALTZ.
Industry payments across MA — which companies pay providers there.
